RecruitingDiabetes Mellitus Type 2
Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric Surgery
Eligible age
18–65 yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The present protocol aims to understand and establish whether there is a causal link between adipose tissue metabolic remodeling and Type 2 Diabetes (T2D) remission after bariatric surgery. All participants will have a bariatric surgery, divided in 2 groups: with or without T2D.
Sponsor: Université de Sherbrooke
You may qualify if…
- ✓ Aged 18 to 65
- ✓ BMI 35 kg/m2
- ✓ Diagnosed T2D - according to Diabetes Canada diagnostics criteria.
- ✓ Diagnosed non-T2D - according to Diabetes Canada diagnostics criteria.
- ✓ Women with a negative serum pregnancy test.
You may not qualify if…
- ✕ Treatment with an oral contraceptive;
- ✕ Treatment with fibrate, thiazolidinedione, insulin, or beta-blocker, drugs that affect metabolism and cannot be stopped temporarily or which have long-lasting effects;
- ✕ Presence of overt cardiovascular disease, liver or renal failure or other uncontrolled medical conditions;
- ✕ Any other contraindication to surgery or to temporarily suspending current medications for diabetes, lipids or hypertension;
- ✕ Smoking or consumption of more than 2 alcoholic beverages per day;
- ✕ Any contraindication to MRI;
- ✕ A Diabetes Remission (DiaRem) score \>8 (low probability of T2D remission);
- ✕ Having participated to a research study with exposure to radiation in the last two years before the start of the study;
Source: ClinicalTrials.gov · NCT05934409 · last updated 2026-02-10